NCPA praises DOJ Task Force on vertical integration and consolidation
ALEXANDRIA, Va. – The National Community Pharmacists Association today issued the following statement on behalf of CEO B. Douglas Hoey in response to an announcement by the U.S.
Pharmacy
NACDS lauds new Tennessee Law enhancing patient access to pharmacy care
NASHVILLE, Tenn. – The National Association of Chain Drug Stores (NACDS) is applauding today the enactment of Tennessee Senate Bill (SB) 869/House Bill (HB) 282, led by State Senator/Pharmacist Shane Reeves (R) and State Representative Charlie Baum (R), respectively.
Pharmacists can help reverse colon cancer’s trajectory
The rise in colon and rectal cancer cases is alarming, with the American Cancer Society reporting colorectal cancer as the leading cause of cancer deaths in men under 50 and the second-leading cause in women of the same age group.
NACDS hails Kentucky Law holding PBMs accountable
FRANKFORT, KY– The National Association of Chain Drug Stores (NACDS) is applauding the Kentucky government for standing up for Kentuckians in the face of “pharmaceutical benefit manipulation” and for enacting meaningful pharmacy benefit manager (PBM) reform in the state.
iA opening new Rx fulfillment innovation hub at redesigned national headquarters
BINGHAMPTON, N.Y. – iA hosted a ribbon-cutting ceremony this week at their newly renovated iA national headquarters.
Sonja Pagniano named new executive director of the NCPA Foundation
The NCPA Foundation is pleased to announce that it has named Sonja Pagniano, CFRE, as its new executive director.
Revelation Pharma announces ConsultRX service
CASTLE ROCK, Colo. – Revelation Pharma announced Thursday the offering of ConsultRX. This powerful nationwide VIP service offered by the company’s network of pharmacies, has the time, expertise and resources that elevates typical pharmacy services through virtual clinical consulting.
NACDS: House Ways & Means action reflects priority status of PBM reform
ARLINGTON, Va. – National Association of Chain Drug Stores (NACDS) President and CEO Steven Anderson issued a statement today as the U.S. House of Representatives Ways and Means Committee marked up legislation that includes some aspects of pharmacy benefit manager (PBM) reform.
CVS to present at the Bank of America 2024 Healthcare Conference
CVS Health announced that chief financial officer Tom Cowhey will participate in a fireside chat with investors at the Bank of America 2024 Healthcare Conference on May 14, 2024, at approximately 7:20 a.m. pacific time.
Rite Aid providing education opportunities for pharmacists during Hepatitis Awareness Month
PHILADELPHIA – Rite Aid is participating in Hepatitis Awareness Month in May by providing additional education opportunities for its pharmacists to learn more about viral hepatitis, an inflammation of the liver that affects more than three million people each year in the U.S.
NACDS hails update of Iowa’s Pharmacy Practice Act
DES MOINES, Iowa – The National Association of Chain Drug Stores (NACDS) is applauding the enactment of the modernization of Iowa’s Pharmacy Practice Act (House File 555), legislation that will help ensure patient access to vital healthcare services provided by pharmacists and pharmacies across the
Soleo Health selected as a specialty pharmacy partner of RYPLAZIM
FRISCO, Texas – Soleo Health, an innovative leader and national provider of complex specialty pharmacy services for treating rare- and ultra-rare diseases, announced today it has been named a limited distribution specialty pharmacy partner to dispense RYPLAZIM® (plasminogen, human-tvmh), manufacture
Amneal aims to settle nationwide opioid cases for $272.5 million
Amneal Pharmaceuticals on Friday announced it is reaching a nationwide $272.5 million settlement agreement that would resolve almost all claims it faces in lawsuits by states, counties, municipalities and Native American tribal nations.
Pharmacy Tech: Revolutionizing health care with cutting-edge solutions
According to the latest BCC Research study, the demand for Pharmacy Automation: Technologies and Global Markets is growing from $7.8 billion in 2023 to $12.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 10.2% from 2023 through 2028.
Dr. Reddy’s announces the launch of doxycycline capsules
HYDERABAD, India – Dr. Reddy’s Laboratories have announced its launch of Doxycycline Capsules, 40 mg* in the U.S. market, a therapeutic generic equivalent of ORACEA (doxycycline, USP) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA). Dr.
NationsBenefits launches NationsBenefits POS
NationsBenefits has officially launched NationsBenefits POS, an all-in-one, handheld, point-of-sale terminal that independent retailers can use to easily transact with eligible health plan members.